ARCHIVES

FDA to refer false statements by regulated companies to SEC.

This article is from The Cancer Letter archive.

Vol. 30 No. 09 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

ACS Increases Funding for Scholar Grants; NCI Posts Interim FY2001 Funding Policy.

December 1, 2000

HPV Vaccine Cervarix Active In 100% Of Women In Study

July 27, 2007

Senate Passes Extension Ac; Kennedy Plans Saccharin Hearing

May 13, 1977

More RFPs Coming On X-Ray imaging For Early Diagnosis, Including Sound

August 23, 1974

Stop Cancer Still Working To Raise Funds

March 22, 1991

ACS President Lawrence Emphasizes Prevention Gains Since 1971

April 10, 1992